PODD
$PODD
Insulet Corporation
Medical device maker of Omnipod tubeless insulin delivery system for diabetes management.
Healthcare$143.52
-4.17 (-2.82%)
Day Range$142.55 - $150.82
Prev Close$147.69
Analyst Rating
Strong Buy
30 Buy / 4 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
This week's analysis
PODD: Omnipod Growth vs Recall Risk
Insulet ($PODD) is trading near its 52-week low after a steep pullback despite strong adoption of Omnipod 5 and a strong analyst consensus. The story is now a balance between durable growth and short-term execution and quality risks ahead of Q1 results on May 6, 2026.
Apr 6, 2026